NCT06066424 2026-04-16
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
M.D. Anderson Cancer Center
Phase 1 Recruiting
Clinical Trials
1,144 trialsNCT06576037 2026-04-16
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06598371 2026-04-16
A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT03016156 2026-04-14
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
St. Jude Children's Research Hospital
Phase NA Terminated
NCT03447483 2026-04-14
MOTIVATE
Institut Claudius Regaud
Phase NA Completed
NCT05071846 2026-04-14
MVX-ONCO-2 in Advanced Solid Tumors
University Hospital, Geneva
Phase 1 Active not recruiting
NCT06198010 2026-04-13
ASCENT
Mayo Clinic
Phase NA Recruiting
NCT06709404 2026-04-13
Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
Wake Forest University Health Sciences
Phase NA Recruiting
NCT07040943 2026-04-13
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
West China Hospital
Phase 1 Recruiting
NCT07141407 2026-04-13
Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT06130254 2026-04-09
Phase Ib Trial of the KRAS G12C Inhibitor Adagrasib (MRTX849) in Combination With the PARP Inhibitor Olaparib in Patients With KRAS G12C Mutated Advanced Solid Tumors, With a Focus on Gynecological, Breast, Pancreatic and KEAP1 Mutated Non-small Cell Lung Cancers
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT07225920 2026-04-08
PGA
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT06383598 2026-04-07
PD-L1 Specific [68Ga]Ga-THP-PDL1-3 Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT06798701 2026-04-07
Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation
Roswell Park Cancer Institute
Phase NA Recruiting
NCT07059884 2026-04-07
DEFEND
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT07443020 2026-04-07
RIOT 4B
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 1 Recruiting
NCT07514793 2026-04-07
Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
Fudan University
Phase 2 Not yet recruiting
NCT05873608 2026-04-06
Communication Issues in Patient and Provider Discussions of Immunotherapy
Emory University
Phase NA Recruiting
NCT06306638 2026-04-06
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Roswell Park Cancer Institute
Phase 1/2 Recruiting
NCT05521984 2026-04-02
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Washington University School of Medicine
Phase 1 Recruiting
NCT06682117 2026-04-02
Neo-DCV-001
Fudan University
Phase NA Recruiting
NCT06630351 2026-04-01
Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness
Mayo Clinic
Phase NA Enrolling by invitation
NCT07504445 2026-03-31
Clinical Study on the Efficacy and Safety of CAR-DC in the Treatment of Advanced Solid Tumors
Peking University Shenzhen Hospital
Phase EARLY_PHASE1 Recruiting
NCT05036226 2026-03-30
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
NCT05223608 2026-03-30
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
NCT05655078 2026-03-30
HIT-Meso
University College, London
Phase NA Recruiting
NCT06342453 2026-03-30
CREATE: Art for Children With Cancer
OHSU Knight Cancer Institute
Phase NA Recruiting
NCT06395441 2026-03-30
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Mayo Clinic
Phase 3 Recruiting
NCT07089927 2026-03-30
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
Mayo Clinic
Phase NA Recruiting
NCT00477958 2026-03-27
Assessment Tool for Older Patients With Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT03678350 2026-03-27
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Roswell Park Cancer Institute
Phase 1 Completed
NCT03997370 2026-03-27
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
NRG Oncology
Phase 1 Active not recruiting
NCT04450043 2026-03-27
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance
Massachusetts General Hospital
Phase NA Active not recruiting
NCT07480733 2026-03-25
Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
NCT06651593 2026-03-24
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06827054 2026-03-24
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
NCT07490236 2026-03-24
Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors
Hebei Medical University Fourth Hospital
Phase 1 Recruiting
NCT02215720 2026-03-20
TORERO
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Completed
NCT03420963 2026-03-20
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02789228 2026-03-19
REST
Children's National Research Institute
Phase 1 Active not recruiting
NCT04823897 2026-03-19
A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours
PharmaMatrix Holdings Ltd
Phase 1 Recruiting
NCT03585465 2026-03-18
Metro-PD1
Centre Oscar Lambret
Phase 1/2 Active not recruiting
NCT05023655 2026-03-17
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Prisma Health-Upstate
Phase 2 Terminated
NCT06927297 2026-03-17
Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors
West China Hospital
Phase 1 Recruiting
NCT06840834 2026-03-16
Bi-MAPS
Intergroupe Francophone de Cancerologie Thoracique
Phase 2 Recruiting
NCT07332312 2026-03-16
A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California
University of Southern California
Phase NA Not yet recruiting
NCT06565260 2026-03-13
Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06771739 2026-03-13
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT07192315 2026-03-13
PREDICTO
Assistance Publique Hopitaux De Marseille
Phase NA Not yet recruiting